Latest Strategic Pivot News

Page 6 of 92
Patrys Limited reported a near doubling of its half-year loss to $3.02 million, driven by restructuring and a strategic pivot including the acquisition of Reliis Pty Ltd. The company is advancing a dual-platform biotech strategy combining a clinical-stage CNS asset with its proprietary antibody platform.
Ada Torres
Ada Torres
26 Feb 2026
Shriro Holdings reported solid half-year growth with revenue up 8.4% and NPAT rising 10%, underpinned by strong BBQ and kitchen appliance sales. The company reaffirmed its EBITDA guidance and announced a $15 million off-market share buy-back for FY26.
Victor Sage
Victor Sage
26 Feb 2026
Aland Equity Group reported a sharp revenue decline and an 85% increase in losses for the half-year ending December 2025, while completing a major capital raise and reshuffling its board.
Claire Turing
Claire Turing
26 Feb 2026
Careteq Limited reported a widening half-year loss with revenues down 18%, announcing plans to sell its Embedded Health Solutions business to strengthen its balance sheet and focus on its HMR Referral platform.
Ada Torres
Ada Torres
26 Feb 2026
Duxton Farms Limited reported a significant half-year loss driven by acquisition and integration costs following a major portfolio expansion. The company is navigating a strategic shift towards diversified agriculture with plans to stabilise earnings over the coming years.
Ada Torres
Ada Torres
26 Feb 2026
US Masters Residential Property Group reported a $57.3 million net loss for 2025 amid a strategic shift to wind down operations by selling its entire US residential property portfolio by the end of 2026. The Group surpassed its aggressive 2025 sales target, setting the stage for capital returns to security holders.
Eva Park
Eva Park
26 Feb 2026
Australian Dairy Nutritionals Group has cut its net loss by 40% in the half-year to December 2025, driven by a remarkable 431% revenue jump in its nutritional powders segment amid expanding Chinese distribution.
Victor Sage
Victor Sage
26 Feb 2026
Percheron Therapeutics reports a 64% reduction in half-year losses to $3.1 million, driven by progress in its licensed immuno-oncology drug HMBD-002 and a strategic pivot away from discontinued assets.
Ada Torres
Ada Torres
26 Feb 2026
Omni Bridgeway Limited reported a striking half-year performance with a 357% jump in net profit and a robust pipeline of legal finance investments. The company’s transformation into a capital-light fund manager is gaining momentum amid favourable regulatory shifts.
Claire Turing
Claire Turing
26 Feb 2026
Eden Innovations is investing in new R&D equipment to enhance its carbon nanotube concrete technology, targeting the booming AI data centre market with improved heat dissipation and electromagnetic shielding.
Victor Sage
Victor Sage
26 Feb 2026
Acusensus Limited reported a robust 40% increase in revenue to $40.3 million for the half-year ended December 2025, driven by new contracts and international growth. However, the company recorded a substantial $20.8 million loss, largely due to a $16 million litigation settlement and strategic investments in future growth.
Sophie Babbage
Sophie Babbage
26 Feb 2026
Black Cat Syndicate has begun processing ore from its Fingals and Majestic mines through the Lakewood Mill and approved a $20 million expansion to boost capacity by 25%, aiming to lower costs and enhance cash flow.
Maxwell Dee
Maxwell Dee
26 Feb 2026